U.S. Contraceptive Market Size Worth $12.0 Billion By 2030
U.S. Contraceptive Industry Overview
The U.S. contraceptive market size is expected to reach USD 12.0 billion by 2030 registering a CAGR of 4.70%, according to a new report by Grand View Research, Inc. Improving access and awareness regarding Long-Acting Reversible Contraceptives (LARCs) and the effectiveness and convenience of using these products are expected to drive the growth of the industry. The Guttmacher Institute reported that 60% of women belonging to the reproductive age use contraception in the U.S. Use of hormonal contraceptives other than the birth control pill has significantly increased in married women.
The increasing availability of contraceptives in the U.S. has improved several aspects of society such as education, career opportunities, and poverty for women. Access to modern methods of contraception has significantly improved career opportunities and allowed women to earn wages at par with men. Moreover, it has also reduced the number of women living in poverty due to unintended pregnancies and the high costs associated with raising a child. The legalization of family planning in the majority of the states has reduced the economic burden for the next generation as there has been a substantial reduction in the number of citizens living in poverty as adults.
U.S. Contraceptive Market Segmentation
Grand View Research has segmented the U.S. contraceptive market on the basis of product:
Based on the Product Insights, the market is segmented into Pills, Intrauterine Devices (IUD) Condoms, Vaginal Ring, Subdermal Implants, Injectable, and Others.
- The popularity of male condoms is high among young individuals due to easy availability, economic pricing, and added advantage of protection against STDs. Moreover, the availability of a vast range of variants in various sizes, flavors, textures, and thickness helps enhance sexual experience of users.
- The U.S. contraceptive market has been segmented into pills, Intrauterine Devices (IUD), condoms, vaginal ring, subdermal implant, injectable, and others. In 2021, oral contraceptives pills accounted for the largest market in 2021 due to large number of products introduced by several market players, a high success rate (99.0% when used perfectly), and convenience in using oral pills for contraception.
- The acceptance of long-acting reversible contraceptives has significantly improved in the last decade. Intrauterine devices, injectables, and vaginal rings are expected to witness sustainable growth during the forecast period. The market is driven by cost-effectiveness and longer duration of product life.
Key Companies Profile & Market Share Insights
The regional market is highly competitive due to the presence of several companies. Most of the companies are undertaking strategic initiatives, such as investments in R&D for developing innovative products and to gain a competitive edge over others. In February 2020, Afaxys, Inc. and TherapeuticsMD, Inc. signed an agreement to increase access to Annovera in the U.S. public healthcare system. In July 2020, TherapeuticsMD, Inc. entered into an agreement with Nurx—an online company for women’s health-for increasing its access to Annovera. High investments by prominent companies for the commercialization of effective and long-term reversible contraceptives have increased the awareness levels about these products. Some of the prominent companies in the U.S. contraceptive market include:
- Church & Dwight Co., Inc.
- Reckitt Benckiser Group Plc
- Veru, Inc.
- Organon Group Of Companies
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cooper Companies, Inc.
- Mayer Laboratories, Inc.
- Agile Therapeutics
- TherapeuticsmMD, Inc.
- Bayer Ag
- Afaxys, Inc.
- Mithra Pharmaceuticals
- Abbvie
Order a free sample PDF of the U.S. Contraceptive Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Browse More Report@ https://www.grandviewresearch.com/research-insights/metaverse-market-snapshot
Comments
Post a Comment